You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 5, 2024

OXYTOCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Oxytocin

A generic version of OXYTOCIN was approved as oxytocin by HIKMA on January 10th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OXYTOCIN?
  • What are the global sales for OXYTOCIN?
  • What is Average Wholesale Price for OXYTOCIN?
Summary for OXYTOCIN
Drug patent expirations by year for OXYTOCIN
Drug Prices for OXYTOCIN

See drug prices for OXYTOCIN

Recent Clinical Trials for OXYTOCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, Gentofte, CopenhagenN/A
University of Colorado, DenverPhase 2
Karolinska InstitutetPhase 2

See all OXYTOCIN clinical trials

Pharmacology for OXYTOCIN
Medical Subject Heading (MeSH) Categories for OXYTOCIN

US Patents and Regulatory Information for OXYTOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys OXYTOCIN oxytocin INJECTABLE;INJECTION 077453-001 Jan 24, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma OXYTOCIN oxytocin INJECTABLE;INJECTION 018243-002 Jan 10, 2007 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa OXYTOCIN oxytocin INJECTABLE;INJECTION 018248-002 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbott OXYTOCIN 10 USP UNITS IN DEXTROSE 5% oxytocin INJECTABLE;INJECTION 019185-003 Mar 29, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma Farmaceutica OXYTOCIN oxytocin INJECTABLE;INJECTION 200219-001 Feb 13, 2013 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbott OXYTOCIN 5 USP UNITS IN DEXTROSE 5% oxytocin INJECTABLE;INJECTION 019185-001 Mar 29, 1985 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.